Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Valbiotis

Explore full profile

Solutions for cardio-metabolic diseases prevention

Perigny, FranceFounded 2014Biotech & Life Sciences
Valuation $25M Market cap · 2026
Revenue $3.4M Latest reported FY
Total funding $10–50M Disclosed equity funding

About Valbiotis

Valbiotis is a research and development company focused on addressing metabolic diseases through scientific innovation. The company operates in the healthcare sector, targeting unmet medical needs with a pipeline of proprietary compounds, including TOTUM 63, TOTUM 070, TOTUM 854, and TOTUM 448. Valbiotis collaborates with global partners, such as HEALTH SCIENCE, to develop and commercialize its products. The business model revolves around advancing these compounds through clinical trials and securing strategic partnerships for commercialization. Valbiotis serves healthcare professionals, investors, and the general public, aiming to provide effective solutions for conditions like hypercholesterolemia and diabetes. The company generates revenue through partnerships and potential product sales upon successful market entry. Valbiotis actively participates in scientific events and publications to maintain its presence in the research community.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Perigny, France
Listing
IPO 2017
Sector
Biotech & Life Sciences

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Sofimac Régions
  • Poitou Charentes Innovation - PCI
  • Nestadio Capital

Series B and later3 investors entered at this stage

  • Friedland Gestion
  • Treecap
  • Maitice Gestion

Talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇫🇷 France95.7%
🇹🇳 Tunisia2.1%
🇳🇱 Netherlands2.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Valbiotis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Valbiotis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles